182 related articles for article (PubMed ID: 36982185)
21. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
Mavroidis P; Ferreira BC; Lopes Mdo C
Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
[TBL] [Abstract][Full Text] [Related]
22. A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning.
Jin JY; Kong FM; Liu D; Ren L; Li H; Zhong H; Movsas B; Chetty IJ
Med Phys; 2011 Jan; 38(1):439-48. PubMed ID: 21361212
[TBL] [Abstract][Full Text] [Related]
23. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans.
Bufacchi A; Arcangeli G; delle Canne S; Malatesta T; Capparella R; Fragomeni R; Marmiroli L; Begnozzi L
Radiother Oncol; 2009 Jul; 92(1):68-75. PubMed ID: 19328571
[TBL] [Abstract][Full Text] [Related]
24. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
25. Ultra-High Dose-Rate, Pulsed (FLASH) Radiotherapy with Carbon Ions: Generation of Early, Transient, Highly Oxygenated Conditions in the Tumor Environment.
Zakaria AM; Colangelo NW; Meesungnoen J; Azzam EI; Plourde MÉ; Jay-Gerin JP
Radiat Res; 2020 Dec; 194(6):587-593. PubMed ID: 32853343
[TBL] [Abstract][Full Text] [Related]
26. Application of the equivalent uniform stochastic dose (EUSD) to TCP calculations incorporating dose uncertainty and fractionation effects.
Zavgorodni S
Australas Phys Eng Sci Med; 2008 Mar; 31(1):1-9. PubMed ID: 18488958
[TBL] [Abstract][Full Text] [Related]
27. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
28. Implementation of novel measurement-based patient-specific QA for pencil beam scanning proton FLASH radiotherapy.
Huang S; Yang Y; Wei S; Kang M; Tsai P; Chen CC; Yuan Z; Choi JI; Tome WA; Simone CB; Lin H
Med Phys; 2023 Jul; 50(7):4533-4545. PubMed ID: 37198998
[TBL] [Abstract][Full Text] [Related]
29. Dose prescription complexity versus tumor control probability in biologically conformal radiotherapy.
South CP; Evans PM; Partridge M
Med Phys; 2009 Oct; 36(10):4379-88. PubMed ID: 19928068
[TBL] [Abstract][Full Text] [Related]
30. Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis.
Böhlen TT; Germond JF; Petersson K; Ozsahin EM; Herrera FG; Bailat C; Bochud F; Bourhis J; Moeckli R; Adrian G
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):1007-1017. PubMed ID: 37276928
[TBL] [Abstract][Full Text] [Related]
31. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
Siedschlag C; Boersma L; van Loon J; Rossi M; van Baardwijk A; Gilhuijs K; Stroom J
Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665
[TBL] [Abstract][Full Text] [Related]
32. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
[TBL] [Abstract][Full Text] [Related]
33. Possible mechanisms and simulation modeling of FLASH radiotherapy.
Shiraishi Y; Matsuya Y; Fukunaga H
Radiol Phys Technol; 2024 Mar; 17(1):11-23. PubMed ID: 38184508
[TBL] [Abstract][Full Text] [Related]
34. 3D-conformal very-high energy electron therapy as candidate modality for FLASH-RT: A treatment planning study for glioblastoma and lung cancer.
Böhlen TT; Germond JF; Traneus E; Vallet V; Desorgher L; Ozsahin EM; Bochud F; Bourhis J; Moeckli R
Med Phys; 2023 Sep; 50(9):5745-5756. PubMed ID: 37427669
[TBL] [Abstract][Full Text] [Related]
35. Trade-off in healthy tissue sparing of FLASH and fractionation in stereotactic proton therapy of lung lesions with transmission beams.
Habraken S; Breedveld S; Groen J; Nuyttens J; Hoogeman M
Radiother Oncol; 2022 Oct; 175():231-237. PubMed ID: 35988773
[TBL] [Abstract][Full Text] [Related]
36. Modeling for predicting survival fraction of cells after ultra-high dose rate irradiation.
Shiraishi Y; Matsuya Y; Kusumoto T; Fukunaga H
Phys Med Biol; 2023 Dec; 69(1):. PubMed ID: 38056015
[No Abstract] [Full Text] [Related]
37. Effect of heterogeneity in radiosensitivity on LQ based isoeffect formalism for low alpha/beta cancers.
Moiseenko V
Acta Oncol; 2004; 43(5):499-502. PubMed ID: 15360056
[TBL] [Abstract][Full Text] [Related]
38. Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model.
Strigari L; Torriani F; Manganaro L; Inaniwa T; Dalmasso F; Cirio R; Attili A
Phys Med Biol; 2018 Mar; 63(6):065012. PubMed ID: 28862152
[TBL] [Abstract][Full Text] [Related]
39. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
Lu JY; Lin PX; Huang BT
Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
[TBL] [Abstract][Full Text] [Related]
40. Ultra-high dose rate FLASH radiation therapy for cancer.
Kim MM; Zou W
Med Phys; 2023 Jun; 50 Suppl 1(Suppl 1):58-61. PubMed ID: 36758965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
